NICHOL GEOFFREY 4
4 · Tempest Therapeutics, Inc. · Filed Jun 14, 2024
Insider Transaction Report
Form 4
NICHOL GEOFFREY
Director
Transactions
- Award
Stock Option (right to buy)
2024-06-13+16,000→ 16,000 totalExercise: $3.03Exp: 2034-06-12→ Common Stock (16,000 underlying)
Footnotes (1)
- [F1]The shares underlying the option will vest in full on the earlier of (i) June 13, 2025, or (ii) the day of the Issuer's 2025 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date.